Latest Financial Results
Q3 2024
Quarter Ended Sep 30, 2024
Stock Information
Company Overview
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investor Contact Information
Company
Kane Biotech Inc.
290-100 Innovation Drive
Winnipeg, MB R3T 6G2
Canada
T: (204) 453-1301
ir@kanebiotech.com
Investor Relations
Kane Biotech Inc.
Nicole Sendey
Investor Relations & Public Relations
T: 204-453-1301
nsendey@kanebiotech.com
Transfer Agent
Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1